TYVASO DPI IS NOW APPROVED

Skip to main content

For the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve exercise ability.

FOR US HEALTHCARE PROFESSIONALS ONLY

Skip to main content

CONTACT US

For more information about TYVASO, please use the contact information below:

Questions about TYVASO or United Therapeutics?

Call 1-877-UNITHER (1-877-864-8437).